Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo-Reference-Cited by-同舟云学术

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo

Published:2012-04 Issue:4 Volume:2 Page:e64-e64
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Kiziltepe T,Ashley J D,Stefanick J F,Qi Y M,Alves N J,Handlogten M W,Suckow M A,Navari R M,Bilgicer B

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201210.pdf

Reference47 articles.

1. Mitsiades CS, Davies FE, Laubach JP, Joshua D, San Miguel J, Anderson KC et al . Future directions of next-generation novel therapies, combination approaches, and the development of personalized medicine in myeloma . J Clin Oncol 2011 ; 29 : 1916 – 1923 .

2. Hideshima T, Richardson P, Anderson K . Novel therapeutic approaches for multiple myeloma . Immunol Rev 2003 ; 194 : 164 – 176 .

3. Sanz-Rodriguez F, Teixido J . VLA-4-dependent myeloma cell adhesion . Leuk Lymphoma 2001 ; 41 : 239 – 245 .

4. Damiano J, Cress A, Hazlehurst L, Shtil A, Dalton W . Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines . Blood 1999 ; 93 : 1658 – 1667 .

5. Schmidmaier R, Baumann P . ANTI-ADHESION evolves to a promising therapeutic concept in oncology . Curr Med Chem 2008 ; 15 : 978 – 990 .

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in drugs restructured with nanomedicines for multiple myeloma treatment;Science China Materials;2024-09-10

2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

3. Extracellular vesicles: powerful candidates in nano-drug delivery systems;Drug Delivery and Translational Research;2023-08-15

4. Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles;Pharmaceutics;2023-05-27

5. A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78;Nanoscale;2023